Yet another batch of blood pressure drugs were recalled by officials over fears of traces of a cancer-causing chemical.

The drug that is recalled is Valsartan which was originally developed by Novartis and marketed as Diovan, but it is not off patent. Patients living in the United States are able to use generic versions from various companies around the world. Concerns over the drug started last summer when it was revealed that some produced in China had been contaminated with a carcinogen called NDEA, prompting a global recall.

American regulators say that Aurobindo Pharma Ltd, an Indian generic drugmaker, will recall 80 lots of medicines containing the blood pressure drug for the same reason. The FDA explained that the impurity NDEA (N-Nitrosodiethylamine) was found in quantities above the acceptable limit in certain tablets containing valsartan.

This recall has highlighted just how heavily people all over the globe rely on medications that are made in India and China. In fact, experts say that two-thirds of all active drug ingredients originate in China and India officials have promised to respond to this by intensifying their inspections even more.

“We need to think globally and work strategically with partners from around the world to make best use of our inspection capacity, so that patients can rely on the quality, safety and efficacy of all medicines, no matter where they have been manufactured,” said the European Medicines Agency’s Executive Director Guido Rasi.

If you or a loved one has used this medication or something like it, please consult your doctor immediately!